資料請求はこちら ▶


慢性腎臓病(CKD) 【新着】

  • 165 Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease. Can J Vet Res.2021
  • 164 Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients. J Med Biochem.2020
    doi: 10.2478/jomb-2019-0037. PubMed
  • 163 Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism. J Vet Intern Med.2021
    doi: 10.1111/jvim.16074. PubMed
  • 162 Predictive value of novel biomarkers for chronic kidney disease among workers occupationally exposed to silica. Toxicol Ind Health.2021
    doi: 10.1177/0748233721990304. PubMed
  • 慢性腎臓病(CKD)関連文献の一覧へ ▶

    急性腎障害(AKI) 【新着】

    • 159Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients. Am J Transplant. 2020
      doi: 10.1111/ajt.16312.PubMed
    • 156Urinary biomarkers of kidney tubule injury, risk of acute kidney injury, and mortality in patients with acute ischaemic stroke treated at a stroke care unit. Eur J Neurol.2020
      doi: 10.1111/ene.14448.PubMed
    • 155Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor.2020
      doi: 10.1097/CCE.0000000000000170.PubMed

    急性腎障害(AKI)関連文献の一覧へ ▶

    薬剤性腎障害(Toxicology) 【新着】

    • 153 Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients. Hepatol Res.2020
      doi: 10.1111/hepr.13451. PubMed
    • 145The influence of renal function by ibuprofen treatment for patent ductus arteriosus in extremely low-birth-weight infants.Pediatr Int.2019PubMed
    • 140Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study.J Pharm Health Care Sci.2019PubMed

    薬剤性腎障害(Toxicology)関連文献の一覧へ ▶

    薬理学(Pharmacology) 【新着】

    • 138Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.Diabetol Int.2018PubMed
    • 136Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.Naunyn Schmiedebergs Arch Pharmacol.2018PubMed
    • 129Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucoselowering-independent manner.BMJ Open Diabetes Res Care.2017PubMed

    薬理学(Pharmacology)関連文献の一覧へ ▶

    運動(Exercise) 【新着】

    • 148 Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: a post-hoc analysis of a randomized controlled trial. Ther Apher Dial.2020PubMed
    • 139Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice.Hypertens Res.2019PubMed
    • 124Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.Clin Exp Hypertens.2017PubMed

    運動(Exercise)関連文献の一覧へ ▶

    日本語総説 【新着】

    • J46 慢性腎臓病の重症化予防に向けた運動の役割 体力科学誌2019
    • J45 習慣的な運動による老化関連疾患の予防医学のあゆみ2018
    • J44 SGLT2 阻害薬ルセオグリフロジンの腎機能障害合併2 型糖尿病患者に対する有用性の検討 診療と新薬55, 2018

    日本語総説の一覧へ ▶


    一覧へ ▶


    資料請求はこちら ▶



尿中L-FABP をサンドイッチ法で比色定量するELISAキットです。対象動物:ラット、イヌ、ネコ、サル、ブタ。



レナプロ® L-FABPテスト

TOPへ ▲
TOPページへ ▶